On Monday, Cg Oncology Inc (NASDAQ: CGON) was 5.47% up from the session before settling in for the closing price of $27.05. A 52-week range for CGON has been $23.91 – $46.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -45.67% over the past five years. When this article was written, the company’s average yearly earnings per share was at -33.65%. With a float of $46.41 million, this company’s outstanding shares have now reached $67.54 million.
Let’s look at the performance matrix of the company that is accounted for 61 employees. In terms of profitability, gross margin is 97.81%, operating margin of -13969.15%, and the pretax margin is -10578.22%.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cg Oncology Inc stocks. The insider ownership of Cg Oncology Inc is 39.60%, while institutional ownership is 66.60%. The most recent insider transaction that took place on Mar 17 ’25, was worth 28,000. In this transaction Director of this company sold 1,000 shares at a rate of $28.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Director proposed sale 4,000 for $27.80, making the entire transaction worth $111,200.
Cg Oncology Inc (CGON) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -33.65% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
You can see what Cg Oncology Inc (CGON) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 35.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3223.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.11 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Cg Oncology Inc (NASDAQ: CGON) saw its 5-day average volume 0.88 million, a positive change from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 67.80%. Additionally, its Average True Range was 1.49.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 27.92%, which indicates a significant decrease from 90.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.46% in the past 14 days, which was higher than the 49.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.10, while its 200-day Moving Average is $32.79. Nevertheless, the first resistance level for the watch stands at $29.22 in the near term. At $29.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.08. If the price goes on to break the first support level at $27.36, it is likely to go to the next support level at $26.20. The third support level lies at $25.51 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
There are 76,038K outstanding shares of the company, which has a market capitalization of 2.19 billion. As of now, sales total 200 K while income totals -48,610 K. Its latest quarter income was 40 K while its last quarter net income were -20,410 K.
